It is essential to differentiate between symptoms arising from the medication, those related to improved diabetes control, and those due to concurrent conditions such as urinary tract infections or overactive bladder syndrome
GLP-1 medications may not be suitable for individuals with: History of pancreatitis (not recommended per UK SmPCs) Severe gastrointestinal disease or gastroparesis (caution advised) Diabetic retinopathy, particularly for semaglutide (requires monitoring) Pregnancy, planning pregnancy, or breastfeeding (contraindicated
These side effects can make your skin look older and more worn out
Research Peptide Peptides sold for research purposes only, not approved by Health Canada for human use
What gets impaired is your ability to feed those processes adequately
Some people start noticing appetite suppression within the first 1 to 4 weeks, even at the starting dose of 0.25mg